Showing results (371-380 of 1,360) with videos related to
Sort By:
Pageof 136
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
Lymphocyte function in human bone marrow. I. Characterization of two T cell populations regulating immunoglobulin secretionG B Mills, C J Ledgley, T Hibi, et al.Applied and Environmental Microbiology|November 25, 2010
Application of a depositional facies model to an acid mine drainage siteJuliana F Brown, Daniel S Jones, Daniel B Mills, et al.BMC Cancer|February 11, 2018
Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitroOzlem Aslan, Mattia Cremona, Clare Morgan, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Phosphatidylinositol 3-kinase is required for CD28 but not CD3 regulation of the TEC family tyrosine kinase EMT/ITK/TSK: functional and physical interaction of EMT with phosphatidylinositol 3-kinaseY Lu, B Cuevas, S Gibson, et al.Cancer Research|April 19, 2005
Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/protein kinase B inhibitorsHayato Takeuchi, Yasuko Kondo, Keishi Fujiwara, et al.Biochemistry|December 19, 1995
A noncanonical tertiary conformation of a human mitochondrial transfer RNAM A Leehey, C A Squassoni, M W Friederich, et al.The Journal of Biological Chemistry|June 25, 1983
The biochemical characterization of detergent-solubilized insulin-like growth factor II receptors from rat placentaJ F Perdue, J K Chan, C Thibault, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
The outcome of heregulin-induced activation of ovarian cancer cells depends on the relative levels of HER-2 and HER-3 expressionF Xu, Y Yu, X F Le, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV)G S Hagopian, G B Mills, A R Khokhar, et al.British Journal of Cancer|November 30, 2019
Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancersMusaffe Tuna, Zhenlin Ju, Kosuke Yoshihara, et al.Pageof 136